Avenzo Therapeutics

Recent Finacing

Series B

Recent Raise

$60M

Avenzo Therapeutics is a San Diego–based clinical-stage biotechnology company developing next-generation oncology therapies, including small-molecule CDK inhibitors and bispecific antibody-drug conjugates.

Founded 2022

California, United States

11-50

Private

avenzotx.com